Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 2
2006 1
2009 3
2010 1
2011 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Mouse models of Huntington's disease and methodological considerations for therapeutic trials.
Ferrante RJ. Ferrante RJ. Biochim Biophys Acta. 2009 Jun;1792(6):506-20. doi: 10.1016/j.bbadis.2009.04.001. Epub 2009 Apr 10. Biochim Biophys Acta. 2009. PMID: 19362590 Free PMC article. Review.
Translating therapies for Huntington's disease from genetic animal models to clinical trials.
Hersch SM, Ferrante RJ. Hersch SM, et al. NeuroRx. 2004 Jul;1(3):298-306. doi: 10.1602/neurorx.1.3.298. NeuroRx. 2004. PMID: 15717031 Free PMC article. Review.
Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein.
Fox JH, Connor T, Stiles M, Kama J, Lu Z, Dorsey K, Lieberman G, Sapp E, Cherny RA, Banks M, Volitakis I, DiFiglia M, Berezovska O, Bush AI, Hersch SM. Fox JH, et al. J Biol Chem. 2011 May 20;286(20):18320-30. doi: 10.1074/jbc.M110.199448. Epub 2011 Mar 30. J Biol Chem. 2011. PMID: 21454633 Free PMC article.
Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease.
Kim J, Amante DJ, Moody JP, Edgerly CK, Bordiuk OL, Smith K, Matson SA, Matson WR, Scherzer CR, Rosas HD, Hersch SM, Ferrante RJ. Kim J, et al. Biochim Biophys Acta. 2010 Jul-Aug;1802(7-8):673-81. doi: 10.1016/j.bbadis.2010.05.001. Epub 2010 May 9. Biochim Biophys Acta. 2010. PMID: 20460152 Free PMC article.
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.
Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ. Ryu H, et al. Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19176-81. doi: 10.1073/pnas.0606373103. Epub 2006 Dec 1. Proc Natl Acad Sci U S A. 2006. PMID: 17142323 Free PMC article.
Antioxidants modulate mitochondrial PKA and increase CREB binding to D-loop DNA of the mitochondrial genome in neurons.
Ryu H, Lee J, Impey S, Ratan RR, Ferrante RJ. Ryu H, et al. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13915-20. doi: 10.1073/pnas.0502878102. Epub 2005 Sep 16. Proc Natl Acad Sci U S A. 2005. PMID: 16169904 Free PMC article.
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival.
Lee J, Kim CH, Simon DK, Aminova LR, Andreyev AY, Kushnareva YE, Murphy AN, Lonze BE, Kim KS, Ginty DD, Ferrante RJ, Ryu H, Ratan RR. Lee J, et al. J Biol Chem. 2005 Dec 9;280(49):40398-401. doi: 10.1074/jbc.C500140200. Epub 2005 Oct 5. J Biol Chem. 2005. PMID: 16207717 Free PMC article.
Chemotherapy for the brain: the antitumor antibiotic mithramycin prolongs survival in a mouse model of Huntington's disease.
Ferrante RJ, Ryu H, Kubilus JK, D'Mello S, Sugars KL, Lee J, Lu P, Smith K, Browne S, Beal MF, Kristal BS, Stavrovskaya IG, Hewett S, Rubinsztein DC, Langley B, Ratan RR. Ferrante RJ, et al. J Neurosci. 2004 Nov 17;24(46):10335-42. doi: 10.1523/JNEUROSCI.2599-04.2004. J Neurosci. 2004. PMID: 15548647 Free PMC article.
Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.
Yang L, Calingasan NY, Wille EJ, Cormier K, Smith K, Ferrante RJ, Beal MF. Yang L, et al. J Neurochem. 2009 Jun;109(5):1427-39. doi: 10.1111/j.1471-4159.2009.06074.x. Epub 2009 Mar 28. J Neurochem. 2009. PMID: 19476553 Free PMC article.
Activation of Ets-2 by oxidative stress induces Bcl-xL expression and accounts for glial survival in amyotrophic lateral sclerosis.
Lee J, Kannagi M, Ferrante RJ, Kowall NW, Ryu H. Lee J, et al. FASEB J. 2009 Jun;23(6):1739-49. doi: 10.1096/fj.08-121046. Epub 2009 Jan 29. FASEB J. 2009. PMID: 19179380 Free PMC article.